Pancreatic Cancer Research

ResearcherUniversity of ToyamaActive in the last 2 years

Shinya Kajiura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4920-5130; OpenAlex author ID A5056456991, A5086957005. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 6 papers

Papers 8

  1. Third-Line Treatment Timing After Second-Line Discontinuation in Advanced Pancreatic Cancer: A 30-Day Landmark Analysis. First author DOI 10.1007/s12029-026-01565-0↗
  2. Clinical trajectories from first-line chemotherapy to best supportive care in unresectable pancreatic cancer: a 10-year real-world retrospective study. Co-author DOI 10.1016/j.ctarc.2026.101409↗
  3. Chemotherapy for Unresectable Pancreatic Cancer Complicated by Disseminated Intravascular Coagulation: A Retrospective Cohort Study. Co-author DOI 10.1097/mpa.0000000000002707↗
  4. Three-Week Monitoring After Anamorelin Initiation in Unresectable or Recurrent Pancreatic Cancer: Dietary Intake Category, Observed Body Weight, and Prognostic… First author DOI 10.1177/10966218261457190↗
  5. Longitudinal Changes in Inflammatory and Nutritional Status Are Associated With Survival in Advanced Pancreatic Cancer. Co-author DOI 10.1177/10966218261500247↗
  6. Facility-Level Availability of Japanese Society of Medical Oncology Specialists and Recorded First-Line Treatment-Process Duration in Pancreatic Cancer: A Nati… Co-author DOI 10.3390/curroncol33070393↗
  7. Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgrou… Co-author DOI 10.1093/jjco/hyad044↗
  8. Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan… Co-author DOI 10.1136/bmjopen-2021-048833↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nobuhiko Hayashi · 5 shared papers, 2026 · strength 1.33
  2. Banri Ogino · 5 shared papers, 2026 · strength 1.33
  3. Ichiro Yasuda · 5 shared papers, 2026 · strength 1.33
  4. Kohei Nagata · 4 shared papers, 2026 · strength 1.07
  5. Kazuto Tajiri · 3 shared papers, 2026 · strength 0.81
  6. Ryuji Hayashi · 2 shared papers, 2026 · strength 0.69
  7. Kentaro Sudo · 1 shared paper, 2023 · strength 0.12
  8. Satoaki Nakamura · 1 shared paper, 2023 · strength 0.12
  9. Naoya Kato · 1 shared paper, 2023 · strength 0.12
  10. Toshio Nakagohri · 1 shared paper, 2023 · strength 0.12
  11. Nobumasa Mizuno · 1 shared paper, 2023 · strength 0.12
  12. Tatsuya Ioka · 1 shared paper, 2023 · strength 0.12
  13. Satoshi Kobayashi · 1 shared paper, 2023 · strength 0.12
  14. Hiroshi Ishii · 1 shared paper, 2023 · strength 0.12
  15. Masafumi Ikeda · 1 shared paper, 2023 · strength 0.12
  16. Naohiro Okano · 1 shared paper, 2023 · strength 0.12
  17. Keiji Sano · 1 shared paper, 2023 · strength 0.12
  18. Masato Ozaka · 1 shared paper, 2023 · strength 0.12
  19. Ryoji Takada · 1 shared paper, 2023 · strength 0.12
  20. Kunihito Gotoh · 1 shared paper, 2023 · strength 0.12
  21. Akiko Todaka · 1 shared paper, 2023 · strength 0.12
  22. Hironori Yamaguchi · 1 shared paper, 2023 · strength 0.12
  23. Junji Furuse · 1 shared paper, 2023 · strength 0.12
  24. Mitsugu Sekimoto · 1 shared paper, 2023 · strength 0.12
  25. Nao Fujimori · 1 shared paper, 2023 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.